Task Force (USPSTF) recommendation statement on screening for ovarian cancer. Methods: A 2008 review of the literature commissioned by the USPSTF revealed no new evidence about the benefits of screening for ovarian cancer but provided some new data about observed harms of screening. A bridge search to 2011 focused on evidence from randomized, controlled trials. Population: This recommendation applies to asymptomatic women. It does not apply to women with known genetic mutations that increase their risk for ovarian cancer (for example, BRCA mutations)
Importance: Potentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2...
© 2019 American Medical Association. All rights reserved. Importance: Potentially harmful mutations ...
The U.S. Preventive Services Task Force (USPSTF), apanel that does not include urologists or cancer ...
ImportanceWith approximately 14 000 deaths per year, ovarian cancer is the fifth most common cause o...
Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ov...
This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendation on...
CA125 have been suggested, however none of these have the sensitivity or specificity to be recommend...
Force (USPSTF) recommendation statement on screening for pros-tate cancer. Methods: The USPSTF revie...
(USPSTF) recommends against routine screening for testicular cancer in asymptomatic adolescent and a...
ImportanceMany conditions that can affect women's health are often evaluated through pelvic examinat...
Force (USPSTF) recommendation statement on screening for breast cancer in the general population. Me...
Importance:Ovarian cancer is relatively rare but the fifth-leading cause of cancer mortality among U...
Force (USPSTF) recommendation statement on screening for skin cancer. Methods: To update its recomme...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
Description: Update of the 2002 U. S. Preventive Services Task Force (USPSTF) recommendation stateme...
Importance: Potentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2...
© 2019 American Medical Association. All rights reserved. Importance: Potentially harmful mutations ...
The U.S. Preventive Services Task Force (USPSTF), apanel that does not include urologists or cancer ...
ImportanceWith approximately 14 000 deaths per year, ovarian cancer is the fifth most common cause o...
Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ov...
This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendation on...
CA125 have been suggested, however none of these have the sensitivity or specificity to be recommend...
Force (USPSTF) recommendation statement on screening for pros-tate cancer. Methods: The USPSTF revie...
(USPSTF) recommends against routine screening for testicular cancer in asymptomatic adolescent and a...
ImportanceMany conditions that can affect women's health are often evaluated through pelvic examinat...
Force (USPSTF) recommendation statement on screening for breast cancer in the general population. Me...
Importance:Ovarian cancer is relatively rare but the fifth-leading cause of cancer mortality among U...
Force (USPSTF) recommendation statement on screening for skin cancer. Methods: To update its recomme...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
Description: Update of the 2002 U. S. Preventive Services Task Force (USPSTF) recommendation stateme...
Importance: Potentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2...
© 2019 American Medical Association. All rights reserved. Importance: Potentially harmful mutations ...
The U.S. Preventive Services Task Force (USPSTF), apanel that does not include urologists or cancer ...